15/12/2025
A blood test that can detect cancer years before symptoms appear could change everything.
Scientists at Johns Hopkins University have developed a powerful new blood test capable of spotting cancer up to three years before it would normally be diagnosed—long before symptoms begin.
The study, published in Cancer Discovery, analyzed archived blood samples from participants in a large NIH-funded cardiovascular research project. Among people who later developed cancer, researchers discovered tiny fragments of tumor-related DNA circulating in the bloodstream years in advance. These genetic clues were present even when the individuals felt completely healthy.
This approach, known as multicancer early detection (MCED), works by identifying trace amounts of cancer DNA shed by tumors into the blood. In several cases, warning signs appeared more than three years before clinical diagnosis, offering a critical window for early monitoring and intervention.
While scientists are still working to determine the best medical response after an early positive result, the implications are enormous. If validated through larger trials, this test could eventually become part of routine health checkups, shifting cancer care from late-stage treatment to early prevention—where survival rates are dramatically higher.
Early detection has always been the biggest advantage in cancer treatment. This technology could finally give doctors—and patients—that head start.
Source:
Cancer Discovery — Johns Hopkins University study on multicancer early detection (MCED), NIH-funded research